Dr. ID: 59883
Stefan Steurer
Publications
- 2015
FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma
Loga, K., Kohlhaussen, J., Burkhardt, L., Simon, R., Steurer, S., Burdak-Rothkamm, S., Jacobsen, F., Sauter, G. & Krech, T., 2015, In: PLOS ONE. 10, 11, p. e0141867Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
Melling, N., Harutyunyan, L., Hube-Magg, C., Kluth, M., Simon, R., Lebok, P., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Steurer, S., Izbicki, J., Sauter, G., Wilczak, W., Schlomm, T. & Krech, T., 2015, In: PLOS ONE. 10, 7, p. e0134614Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
Burdelski, C., Bujupi, E., Tsourlakis, M. C., Hube-Magg, C., Kluth, M., Melling, N., Lebok, P., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Wilczak, W., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: PLOS ONE. 10, 6, p. e0128525Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
Burdelski, C., Menan, D., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: BMC CANCER. 15, p. 538Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy
Tsourlakis, M. C., Khosrawi, P., Weigand, P., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Krech, T., Wilczak, W., Huland, H., Simon, R., Schlomm, T. & Steurer, S., 2015, In: INT J MOL SCI. 16, 4, p. 8591-606 16 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2014
Histopathological Characteristics of Buccal Mucosa Transplants in Humans after Engraftment to the Urethra: A Prospective Study
Soave, A., Steurer, S., Dahlem, R., Rink, M., Reiss, P., Fisch, M. & Engel, O., 01.12.2014, In: J UROLOGY. 192, 6, p. 1725-9 5 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays
Steurer, S., Singer, J. M., Rink, M., Chun, F., Dahlem, R., Simon, R., Burandt, E., Stahl, P., Terracciano, L., Schlomm, T., Wagner, W., Höppner, W., Omidi, M., Kraus, O., Kwiatkowski, M., Doh, O., Fisch, M., Soave, A., Sauter, G., Wurlitzer, M., Schlüter, H. & Minner, S., 01.11.2014, In: UROL ONCOL-SEMIN ORI. 32, 8, p. 1225-33 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
Grupp, K., Boumesli, R., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 15.09.2014, In: INT J CANCER. 135, 6, p. 1399-1407Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer
Steurer, S., Mayer, P. S., Adam, M., Krohn, A., Koop, C., Ospina-Klinck, D., Tehrani, A. A., Simon, R., Tennstedt, P., Graefen, M., Wittmer, C., Brors, B., Plass, C., Korbel, J., Weischenfeldt, J., Sauter, G., Huland, H., Tsourlakis, M. C., Minner, S. & Schlomm, T., 08.07.2014, In: EUR UROL. 66, 6, p. 978-981Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer
Grupp, K., Ospina-Klinck, D., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Simon, R., Sauter, G., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 01.07.2014, In: PROSTATE. 74, 10, p. 1012-22 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype
Steurer, S., Seddiqi, A. S., Singer, J. M., Bahar, A. S., Eichelberg, C., Rink, M., Dahlem, R., Huland, H., Sauter, G., Simon, R., Minner, S., Burandt, E., Stahl, P. R., Schlomm, T., Wurlitzer, M. & Schlüter, H., 01.05.2014, In: ANTICANCER RES. 34, 5, p. 2255-61 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer
Krohn, A., Freudenthaler, F., Harasimowicz, S., Kluth, M., Fuchs, S., Burkhardt, L., Stahl, P., C Tsourlakis, M., Bauer, M., Tennstedt, P., Graefen, M., Steurer, S., Sirma, H., Sauter, G., Schlomm, T., Simon, R. & Minner, S., 25.04.2014, In: MODERN PATHOL. 27, 12, p. 1612-1620Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions
Grupp, K., Wilking, J., Prien, K., Hube-Magg, C., Sirma, H., Simon, R., Steurer, S., Budäus, L., Haese, A., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.03.2014, In: EUR J CANCER. 50, 4, p. 852-61 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score
Hansen, J., Bianchi, M., Sun, M., Rink, M., Castiglione, F., Abdollah, F., Steuber, T., Ahyai, S. A., Steurer, S., Göbel, C., Freschi, M., Montorsi, F., Shariat, S. F., Fisch, M., Graefen, M., Karakiewicz, P. I., Briganti, A. & Chun, F. K-H., 01.03.2014, In: BJU INT. 113, 3, p. 399-407 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Tsourlakis, M. C., Weigand, P., Grupp, K., Kluth, M., Steurer, S., Schlomm, T., Graefen, M., Huland, H., Salomon, G., Steuber, T., Wilczak, W., Sirma, H., Simon, R., Sauter, G., Minner, S. & Quaas, A., 01.03.2014, In: AM J PATHOL. 184, 3, p. 609-17 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy
Adam, M., Hannah, A., Budäus, L., Steuber, T., Salomon, G., Michl, U., Haese, A., Fisch, M., Wittmer, C., Steurer, S., Minner, S., Heinzer, H., Huland, H., Graefen, M., Sauter, G., Schlomm, T. & Isbarn, H., 08.02.2014, In: J UROLOGY. 192, 1, p. 97-101Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
Grupp, K., Habermann, M., Sirma, H., Simon, R., Steurer, S., Hube-Magg, C., Prien, K., Burkhardt, L., Jedrzejewska, K., Salomon, G., Heinzer, H., Wilczak, W., Kluth, M., Izbicki, J. R., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.01.2014, In: MODERN PATHOL. 27, 1, p. 96-106 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2013
Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis
Sirma, H., Broemel, M., Stumm, L., Tsourlakis, M. C., Steurer, S., Tennstedt, P., Salomon, G., Michl, U., Haese, A., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 01.11.2013, In: ONCOL LETT. 6, 5, p. 1245-1252 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence
Grupp, K., Diebel, F., Sirma, H., Simon, R., Breitmeyer, K., Steurer, S., Hube-Magg, C., Prien, K., Pham, T., Weigand, P., Michl, U., Heinzer, H., Kluth, M., Minner, S., Tsourlakis, M. C., Izbicki, J. R., Sauter, G., Schlomm, T. & Wilczak, W., 01.11.2013, In: PROSTATE. 73, 15, p. 1690-8 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
Grupp, K., Höhne, T. S., Prien, K., Hube-Magg, C., Tsourlakis, M. C., Sirma, H., Pham, T., Heinzer, H., Graefen, M., Michl, U., Simon, R., Wilczak, W., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Steurer, S., 01.10.2013, In: EXP MOL PATHOL. 95, 2, p. 227-34 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
Krohn, A., Seidel, A., Burkhardt, L., Bachmann, F., Mader, M., Grupp, K., Eichenauer, T., Becker, A., Adam, M., Graefen, M., Huland, H., Kurtz, S., Steurer, S., Tsourlakis, M. C., Minner, S., Michl, U., Schlomm, T., Sauter, G., Simon, R. & Sirma, H., 01.09.2013, In: AM J PATHOL. 231, 1, p. 130-41 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
Kluth, M., Hesse, J., Heinl, A., Krohn, A., Steurer, S., Sirma, H., Simon, R., Mayer, P-S., Schumacher, U., Grupp, K., Izbicki, J. R., Pantel, K., Dikomey, E., Korbel, J. O., Plass, C., Sauter, G., Schlomm, T. & Minner, S., 01.07.2013, In: MODERN PATHOL. 26, 7, p. 975-83 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy
Tsourlakis, M. C., Delmo Walter, E. M., Quaas, A., Graefen, M., Huland, H., Simon, R., Sauter, G., Steurer, S., Schlomm, T. & Minner, S., 01.06.2013, In: PROSTATE CANCER P D. 16, 2, p. 159-64 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High mitochondria content is associated with prostate cancer disease progression
Grupp, K., Jedrzejewska, K., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Quaas, A., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Schlomm, T., Minner, S. & Steurer, S., 01.01.2013, In: MOL CANCER. 12, 1, p. 145Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.
Grupp, K., Kohl, S., Sirma, H., Simon, R., Steurer, S., Becker, A., Adam, M., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 2013, In: MODERN PATHOL. 26, 5, p. 733-742 10 p., 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.
Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H-J., Stehr, H., Rausch, T., Jäger, N., Gu, L., Bogatyrova, O., Stütz, A. M., Claus, R., Eils, J., Eils, R., Gerhäuser, C., Huang, P-H., Hutter, B., Kabbe, R., Lawerenz, C., Radomski, S., Bartholomae, C. C., Fälth, M., Gade, S., Schmidt, M., Amschler, N., Hass, T., Galal, R., Gjoni, J., Kuner, R., Baer, C., Masser, S., von Kalle, C., Zichner, T., Benes, V., Raeder, B., Mader, M., Amstislavskiy, V., Avci, M., Lehrach, H., Parkhomchuk, D., Sultan, M., Burkhardt, L., Graefen, M., Huland, H., Kluth, M., Krohn, A., Sirma, H., Stumm, L., Steurer, S., Grupp, K., Sültmann, H., Sauter, G., Plass, C., Brors, B., Yaspo, M-L., Korbel, J. O. & Schlomm, T., 2013, In: CANCER CELL. 23, 2, p. 159-170 12 p., 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.
Steurer, S., Borkowski, C., Odinga, S., Buchholz, M., Koop, C., Huland, H., Becker, M., Witt, M., Trede, D., Omidi, M., Kraus, O., Bahar, A. S., Seddiqi, A. S., Singer, J. M., Kwiatkowski, M., Trusch, M., Simon, R., Wurlitzer, M., Minner, S., Schlomm, T., Sauter, G. & Schlüter, H., 2013, In: INT J CANCER. 133, 4, p. 920-928 9 p., 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.
Stumm, L., Burkhardt, L., Steurer, S., Simon, R., Adam, M., Becker, A., Sauter, G., Minner, S., Schlomm, T., Sirma, H. & Michl, U., 2013, In: J CLIN PATHOL. 66, 7, p. 563-568 6 p., 7.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review